Not applicableApproved For MarketingNCT04300803What this trial is testingExpanded Access Program for Tafasitamab (MOR00208) in R/R DLBCLWho this might be right forDLBCL MorphoSys AG
Early research (Phase 1)Ended earlyNCT03778073What this trial is testingStudy of Cosibelimab in Subjects With Relapsed or Refractory LymphomaWho this might be right forB-cell Non Hodgkin LymphomaRichter's Transformation TG Therapeutics, Inc. 18
Testing effectiveness (Phase 2)Looking for participantsNCT06589089What this trial is testingAutologous Hematopoietic Stem Cell Boost Study After CAR-T TherapyWho this might be right forDiffuse Large B Cell Lymphoma Ruijin Hospital 18
Early research (Phase 1)Looking for participantsNCT06879340What this trial is testingEvaluating the Safety and Efficacy of DuoCAR20.19.22-D95 in Adult Patients With Relapsed or Refractory B-cell MalignanciesWho this might be right forB-Cell Non-Hodgkin LymphomaB-cell Acute Lymphoblastic Leukemia University of Kansas Medical Center 54
Testing effectiveness (Phase 2)UnknownNCT02851589What this trial is testingStudy Evaluating the Efficacy and Safety of PCAR-019 in CD19 Positive Relapsed or Refractory Leukemia and LymphomaWho this might be right forAcute Lymphocytic LeukemiaChronic Lymphocytic LeukemiaFollicular Lymphoma+3 more PersonGen BioTherapeutics (Suzhou) Co., Ltd. 10
Testing effectiveness (Phase 2)UnknownNCT02315118What this trial is testingPilot Study of Autologous T Lymphocytes With ADCC in Patients With CD20-Positive B-Cell MalignanciesWho this might be right forB-Cell Chronic Lymphocytic LeukemiaNon-Hodgkin's Lymphoma National University Hospital, Singapore 18
Early research (Phase 1)Study completedNCT02950220What this trial is testingPembrolizumab and Ibrutinib in Treating Patients With Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forB-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Classical Hodgkin LymphomaGrade 1 Follicular LymphomaGrade 2 Follicular Lymphoma+16 more Kami Maddocks 2
Early research (Phase 1)Study completedNCT02651662What this trial is testingLearn How Safe and Tolerable Odronextamab and Cemiplimab Are in Adult Patients With B-cell MalignanciesWho this might be right forRelapsed/Refractory Aggressive B-Cell Lymphoma Regeneron Pharmaceuticals 105
Not applicableLooking for participantsNCT06785818What this trial is testingLong-term Follow up Local Registry Study of Kymriah in South KoreaWho this might be right forB-Cell Acute Lymphoblastic Leukemia, Diffuse Large B-Cell Lymphoma, Follicular Lymphoma Novartis Pharmaceuticals 500
Very early researchStudy completedNCT03825718What this trial is testingGC007F CAR-T Cell Immunotherapy for Relapsed or Refractory B- ALLWho this might be right forB-cell Acute Lymphoblastic Leukemia Hebei Yanda Ludaopei Hospital 29
Early research (Phase 1)Looking for participantsNCT04545762What this trial is testingAnti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin LymphomaWho this might be right forRefractory Non-Hodgkin LymphomaBurkitt LymphomaMantle Cell Lymphoma+7 more C. Babis Andreadis 36
Early research (Phase 1)Ended earlyNCT00036855What this trial is testingRadiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory LymphomaWho this might be right forAIDS-related Peripheral/Systemic LymphomaAIDS-related Primary CNS LymphomaPost-transplant Lymphoproliferative Disorder+4 more National Cancer Institute (NCI) 36
Early research (Phase 1)Study completedNCT00304018What this trial is testingDonor Umbilical Cord Blood Transplant in Treating Patients With Advanced Hematologic CancerWho this might be right forLeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm+1 more University of California, San Francisco 5
Not applicableLooking for participantsNCT06156774What this trial is testingSARcopenia and Simplified Geriatric Assessment in Lymphoma Patients Undergoing CAR-T Cell Therapy: the FIL_SAR-CAR ProjectWho this might be right forNon-hodgkin Lymphoma,B Cell Fondazione Italiana Linfomi - ETS 130
Large-scale testing (Phase 3)Study completedNCT00075725What this trial is testingDexamethasone Compared With Prednisone During Induction Therapy and Methotrexate With or Without Leucovorin During Maintenance Therapy in Treating Patients With Newly Diagnosed High-Risk Acute Lymphoblastic LeukemiaWho this might be right forAcute Lymphoblastic LeukemiaAdult B Acute Lymphoblastic LeukemiaChildhood B Acute Lymphoblastic Leukemia Children's Oncology Group 3,154
Early research (Phase 1)Study completedNCT00255710What this trial is testingCyclophosphamide and/or Mycophenolate Mofetil With or Without Tacrolimus in Treating Patients Who Are Undergoing a Donor Bone Marrow or Peripheral Stem Cell Transplant for Hematologic CancerWho this might be right forChronic Myeloproliferative DisordersGraft Versus Host DiseaseLeukemia+4 more Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 60
Early research (Phase 1)Study completedNCT00083213What this trial is testingIntravenous VEGF Trap in Treating Patients With Relapsed or Refractory Advanced Solid Tumors or Non-Hodgkin's LymphomaWho this might be right forCancer Regeneron Pharmaceuticals 25
Testing effectiveness (Phase 2)Study completedNCT00107380What this trial is testingS0433 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Treating Older Patients With Stage II, Stage III, or Stage IV Non-Hodgkin's LymphomaWho this might be right forLymphoma SWOG Cancer Research Network 86
Testing effectiveness (Phase 2)Ended earlyNCT03698552What this trial is testingADCT-602 in Treating Patients With Recurrent or Refractory B-cell Acute Lymphoblastic LeukemiaWho this might be right forBlasts 5 Percent or More of Bone Marrow Nucleated CellsCD22 PositivePhiladelphia Chromosome Positive+2 more M.D. Anderson Cancer Center 37
Very early researchStudy completedNCT01184885What this trial is testingA Pilot Study to Determine the Safety and Tolerability of Sirolimus Given With Hyper-CVAD ChemotherapyWho this might be right forLymphoid Malignancies (New or Relapsed)Acute Lymphoblastic LeukemiaBurkitt Lymphoma+3 more Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University 7